These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 33714745)

  • 1. Pragmatic Design of Randomized Clinical Trials for Heart Failure: Rationale and Design of the TRANSFORM-HF Trial.
    Greene SJ; Velazquez EJ; Anstrom KJ; Eisenstein EL; Sapp S; Morgan S; Harding T; Sachdev V; Ketema F; Kim DY; Desvigne-Nickens P; Pitt B; Mentz RJ;
    JACC Heart Fail; 2021 May; 9(5):325-335. PubMed ID: 33714745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On-treatment analysis of torsemide versus furosemide for patients hospitalized for heart failure: A post-hoc analysis of TRANSFORM-HF.
    Kittipibul V; Mentz RJ; Clare RM; Wojdyla DM; Anstrom KJ; Eisenstein EL; Ambrosy AP; Goyal P; Skopicki HA; Ketema F; Kim DY; Desvigne-Nickens P; Pitt B; Velazquez EJ; Greene SJ
    Eur J Heart Fail; 2024 Jul; 26(7):1518-1523. PubMed ID: 38745502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Torsemide Versus Furosemide on Symptoms and Quality of Life Among Patients Hospitalized for Heart Failure: The TRANSFORM-HF Randomized Clinical Trial.
    Greene SJ; Velazquez EJ; Anstrom KJ; Clare RM; DeWald TA; Psotka MA; Ambrosy AP; Stevens GR; Rommel JJ; Alexy T; Ketema F; Kim DY; Desvigne-Nickens P; Pitt B; Eisenstein EL; Mentz RJ;
    Circulation; 2023 Jul; 148(2):124-134. PubMed ID: 37212600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart Failure: The TRANSFORM-HF Randomized Clinical Trial.
    Mentz RJ; Anstrom KJ; Eisenstein EL; Sapp S; Greene SJ; Morgan S; Testani JM; Harrington AH; Sachdev V; Ketema F; Kim DY; Desvigne-Nickens P; Pitt B; Velazquez EJ;
    JAMA; 2023 Jan; 329(3):214-223. PubMed ID: 36648467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Torsemide vs Furosemide Among Patients With New-Onset vs Worsening Chronic Heart Failure: A Substudy of the TRANSFORM-HF Randomized Clinical Trial.
    Krim SR; Anand S; Greene SJ; Chen A; Wojdyla D; Vilaro J; Haught H; Herre JM; Eisenstein EL; Anstrom KJ; Pitt B; Velazquez EJ; Mentz RJ
    JAMA Cardiol; 2024 Feb; 9(2):182-188. PubMed ID: 37955908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Effect of Loop Diuretic Prescription on Mortality and Heart Failure Readmission.
    Virkud AV; Chang PP; Funk MJ; Kshirsagar AV; Edwards JK; Pate V; Kosorok MR; Gower EW
    Am J Cardiol; 2024 Jan; 210():208-216. PubMed ID: 37972425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of baseline kidney dysfunction on oral diuretic efficacy following hospitalization for heart failure - insights from TRANSFORM-HF.
    Martens P; Greene SJ; Mentz RJ; Li S; Wojdyla D; Kapelios CJ; Mullens W; Hall ME; Ketema F; Kim DY; Eisenstein EL; Anstrom K; Fang JC; Pitt B; Velazquez EJ; Tang WHW
    Eur J Heart Fail; 2024 May; 26(5):1242-1250. PubMed ID: 38558520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of torsemide in patients with heart failure and renal disease.
    Peters AE; Mentz RJ; DeWald TA; Greene SJ
    Expert Rev Cardiovasc Ther; 2022 Jan; 20(1):5-11. PubMed ID: 34936522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Torsemide Versus Furosemide After Discharge in Patients Hospitalized With Heart Failure Across the Spectrum of Ejection Fraction: Findings From TRANSFORM-HF.
    Kapelios CJ; Greene SJ; Mentz RJ; Ikeaba U; Wojdyla D; Anstrom KJ; Eisenstein EL; Pitt B; Velazquez EJ; Fang JC;
    Circ Heart Fail; 2024 Mar; 17(3):e011246. PubMed ID: 38436075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Furosemide Versus Torsemide on Hospitalizations and Mortality in Patients With Heart Failure: A Meta-Analysis of Randomized Controlled Trials.
    Singh S; Goel S; Duhan S; Chaudhary R; Garg A; Tantry US; Gurbel PA
    Am J Cardiol; 2023 Nov; 206():42-48. PubMed ID: 37677884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Torsemide versus furosemide and intermediate-term outcomes in patients with heart failure: an updated meta-analysis.
    Miles JA; Hanumanthu BK; Patel K; Chen M; Siegel RM; Kokkinidis DG
    J Cardiovasc Med (Hagerstown); 2019 Jun; 20(6):379-388. PubMed ID: 30950982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive review of the loop diuretics: should furosemide be first line?
    Wargo KA; Banta WM
    Ann Pharmacother; 2009 Nov; 43(11):1836-47. PubMed ID: 19843838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can Torsemide and Combination of Loop Diuretics Improve Mortality in Patients with Chronic Heart Failure After Discharge?
    Yao Y; Zhang J; Zhang Y; Zhang R
    Int Heart J; 2018 Jul; 59(4):813-820. PubMed ID: 29877310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Torsemide versus Furosemide in the Treatment of Heart Failure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Teixeira L; Felix N; Navalha DDP; Ferreira R; Clemente MRC; Madeira T; Nogueira A; Tramujas L
    Arq Bras Cardiol; 2024; 121(6):e20230825. PubMed ID: 39046046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Torsemide Versus Furosemide in Patients With Acute Heart Failure (from the ASCEND-HF Trial).
    Mentz RJ; Hasselblad V; DeVore AD; Metra M; Voors AA; Armstrong PW; Ezekowitz JA; Tang WH; Schulte PJ; Anstrom KJ; Hernandez AF; Velazquez EJ; O'Connor CM
    Am J Cardiol; 2016 Feb; 117(3):404-11. PubMed ID: 26704029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing torsemide versus furosemide in patients with heart failure: A meta-analysis.
    Kido K; Shimizu M; Hashiguchi M
    J Am Pharm Assoc (2003); 2019; 59(3):432-438. PubMed ID: 30846351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diuretic dosing and outcomes with torsemide and furosemide following hospitalization for heart failure: The TRANSFORM-HF trial.
    Nouhravesh N; Greene SJ; Clare R; Wojdyla D; Anstrom KJ; Velazquez E; Pitt B; Mentz RJ; Psotka MA
    Eur J Heart Fail; 2024 Oct; ():. PubMed ID: 39363809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure.
    Murray MD; Deer MM; Ferguson JA; Dexter PR; Bennett SJ; Perkins SM; Smith FE; Lane KA; Adams LD; Tierney WM; Brater DC
    Am J Med; 2001 Nov; 111(7):513-20. PubMed ID: 11705426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Torsemide versus furosemide after acute decompensated heart failure: a retrospective observational study.
    Rahhal A; Saad MO; Tawengi K; Assi AAR; Habra M; Ahmed D
    BMC Cardiovasc Disord; 2019 May; 19(1):127. PubMed ID: 31138146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effectiveness of torsemide versus furosemide in heart failure patients: insights from the PROTECT trial.
    Mentz RJ; Velazquez EJ; Metra M; McKendry C; Chiswell K; Fiuzat M; Givertz MM; Voors AA; Teerlink JR; O'Connor CM
    Future Cardiol; 2015 Sep; 11(5):585-95. PubMed ID: 26403536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.